Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy

NCT00003600 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00003600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 3
Overall status
Completed
Start date
December 31, 1998
Completion date
January 31, 2010
Enrollment
344 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, breast cancer, chronic myeloproliferative disorders, drug/agent toxicity by tissue/organ, leukemia, lung cancer, lymphoma, multiple myeloma and plasma cell neoplasm, precancerous condition, small intestine cancer, unspecified adult solid tumor, protocol specific